Filing Details

Accession Number:
0000899243-22-038836
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-16 17:00:16
Reporting Period:
2022-12-14
Accepted Time:
2022-12-16 17:00:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1851194 Ventyx Biosciences Inc. VTYX Pharmaceutical Preparations (2834) 832996852
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1923805 J. William Sandborn C/O Ventyx Biosciences, Inc.
662 Encinitas Blvd, Suite 250
Encinitas CA 92024
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-14 2,391 $3.54 50,780 No 4 M Direct
Common Stock Acquisiton 2022-12-14 3,189 $1.73 53,969 No 4 M Direct
Common Stock Acquisiton 2022-12-14 16,180 $0.20 70,149 No 4 M Direct
Common Stock Disposition 2022-12-14 21,760 $33.87 48,389 No 4 S Direct
Common Stock Acquisiton 2022-12-14 20,922 $0.20 55,799 No 4 M Indirect By Spouse
Common Stock Disposition 2022-12-14 20,922 $33.87 34,877 No 4 S Indirect By Spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 M Indirect By Spouse
No 4 S Indirect By Spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2022-12-14 2,391 $0.00 2,391 $3.54
Common Stock Stock Option (right to buy) Disposition 2022-12-14 3,189 $0.00 3,189 $1.73
Common Stock Stock Option (right to buy) Disposition 2022-12-14 16,180 $0.00 16,180 $0.20
Common Stock Stock Option (right to buy) Disposition 2022-12-14 20,922 $0.00 20,922 $0.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-02-26 2031-02-26 No 4 M Direct
0 2021-02-26 2031-02-26 No 4 M Direct
32,209 2029-03-27 No 4 M Direct
3,272 2029-03-27 No 4 M Indirect
Footnotes
  1. Represents the weighted average share price of an aggregate total of 21,760 shares sold in the price range of $33.5325 to $34.10. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. Represents the weighted average share price of an aggregate total of 20,922 shares sold in the price range of $33.5325 to $34.10. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2019 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the total shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 6, 2019.
  4. Subject to the Reporting Person's spouse continuing to be a Service Provider (as defined in the Issuer's 2019 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the total shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean February 6, 2019.